Service of Gynecology, Vírgen de la Arrixaca, Murcia, Spain.
Am J Clin Nutr. 2010 Jul;92(1):115-22. doi: 10.3945/ajcn.2010.29589. Epub 2010 May 5.
Fetal growth and development require n-3 (omega-3) long-chain polyunsaturated fatty acids, but mechanisms for their placental transfer are not well understood.
We assessed distribution and human placental transfer of (13)C-labeled fatty acids (FAs) 12 h after oral application.
Eleven pregnant women received 0.5 mg [(13)C]palmitic acid ((13)C-PA; 16:0), 0.5 mg [(13)C]oleic acid ((13)C-OA; 18:1n-9), 0.5 mg [(13)C]linoleic acid ((13)C-LA; 18:2n-6), and 0.1 mg [(13)C]docosahexaenoic acid ((13)C-DHA; 22:6n-3) per kilogram of body weight orally 12 h before elective cesarean section. Maternal blood samples were collected before tracer intake (-12 h) and at -3, -2, -1, 0, and +1 h relative to the time of cesarean section. At birth, venous cord blood and placental tissue were collected, and FA concentrations in individual lipid fractions and their tracer content (atom percent excess values) were determined.
Relatively stable tracer enrichment was achieved in maternal lipid fractions 12 h after tracer administration. In maternal plasma, most (13)C-PA and (13)C-OA were found in triglycerides, whereas (13)C-LA and (13)C-DHA were found mainly in plasma phospholipids and triglycerides. In placental tissue, (13)C-FAs were mainly found in phospholipids, which comprise 80% of placental tissue lipids. Placenta-maternal plasma ratios and fetal-maternal plasma ratios for (13)C-DHA were significantly higher than those for any other FA.
Twelve hours after oral application of (13)C-labeled FAs, relatively stable tracer enrichment was achieved. We found a significantly higher ratio of (13)C-DHA concentrations in cord plasma than in maternal plasma, which was higher than that for the other studied FAs. (13)C-DHA is predominantly esterified into phospholipids and triglycerides in maternal plasma, which may facilitate its placental uptake and transfer.
胎儿的生长发育需要 n-3(ω-3)长链多不饱和脂肪酸,但胎盘对其的转运机制尚不清楚。
我们评估了口服后 12 小时标记脂肪酸(FA)的分布和人胎盘转移。
11 名孕妇在择期剖宫产前 12 小时口服 0.5mg[13C]棕榈酸(13C-PA;16:0)、0.5mg[13C]油酸(13C-OA;18:1n-9)、0.5mg[13C]亚油酸(13C-LA;18:2n-6)和 0.1mg[13C]二十二碳六烯酸(13C-DHA;22:6n-3)/kg 体重。采集母亲血样,在摄入示踪剂前(-12h)和剖宫产时间相对应的-3、-2、-1、0 和+1h 时采集。出生时,采集静脉脐带血和胎盘组织,并测定各脂质部分的 FA 浓度及其示踪剂含量(原子百分比过剩值)。
口服示踪剂 12 小时后,母体脂质部分的示踪剂丰度相对稳定。在母体血浆中,大多数[13C]PA 和[13C]OA 存在于甘油三酯中,而[13C]LA 和[13C]DHA 主要存在于血浆磷脂和甘油三酯中。在胎盘组织中,[13C]FA 主要存在于占胎盘组织脂质 80%的磷脂中。胎盘-母体血浆比和胎儿-母体血浆比的[13C]DHA 均显著高于其他任何 FA。
口服[13C]标记 FA 12 小时后,达到了相对稳定的示踪剂丰度。我们发现脐带血浆中[13C]DHA 浓度与母体血浆相比明显更高,高于其他研究的 FA。[13C]DHA 主要酯化在母体血浆的磷脂和甘油三酯中,这可能有利于其胎盘摄取和转运。